Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9320)
All Articles published online
|
Publishing Process of This Article
|
May 28, 2014 (publication date) through Jul 9, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Carulli L, Anzivino C. Telomere and telomerase in chronic liver disease and hepatocarcinoma. World J Gastroenterol 2014; 20(20): 6287-6292 [PMID: 24876749 DOI: 10.3748/wjg.v20.i20.6287] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i20/6287.htm |
| Number | Citing Articles |
| 1 |
Dzeina Mezale, Ilze Strumfa, Andrejs Vanags, Matiss Mezals, Ilze Fridrihsone, Boriss Strumfs, Dainis Balodis. Liver Cirrhosis - Update and Current Challenges. 2017; doi: 10.5772/intechopen.68771
|
| 2 |
Thais Maloberti, Antonio De Leo, Viviana Sanza, Elisa Gruppioni, Annalisa Altimari, Mattia Riefolo, Michela Visani, Deborah Malvi, Antonia D’Errico, Giovanni Tallini, Francesco Vasuri, Dario de Biase. Correlation of molecular alterations with pathological features in hepatocellular carcinoma: Literature review and experience of an Italian center. World Journal of Gastroenterology 2022; 28(25): 2854-2866 doi: 10.3748/wjg.v28.i25.2854
|
| 3 |
Omneya Y. Bassyoni, Hiam A. Eleleimy, Eman A. Saad. Significance of p53, cyclooxygenase-2, and epithelial cell adhesion molecule expression in hepatocellular carcinoma: an immunohistochemical study. Egyptian Journal of Pathology 2024; 44(1): 39 doi: 10.4103/egjp.egjp_10_24
|
| 4 |
Dora Melicher, Edit I. Buzas, Andras Falus. Genetic and epigenetic trends in telomere research: a novel way in immunoepigenetics. Cellular and Molecular Life Sciences 2015; 72(21): 4095 doi: 10.1007/s00018-015-1991-2
|
| 5 |
Jonathan H. Teichroeb, Joohwan Kim, Dean H. Betts. The role of telomeres and telomerase reverse transcriptase isoforms in pluripotency induction and maintenance. RNA Biology 2016; 13(8): 707 doi: 10.1080/15476286.2015.1134413
|
| 6 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_167-1
|
| 7 |
Wafaa M. Ezzat, Khalda Said Amr, Haiam Abdel Raouf, Yasser A. Elhosary, Abdelfattah E. Hegazy, Hoda H. Fahim, Refaat R. Kamel. Relationship Between Serum microRNA155 and Telomerase Expression in Hepatocellular Carcinoma. Archives of Medical Research 2016; 47(5): 349 doi: 10.1016/j.arcmed.2016.08.003
|
| 8 |
Endang Purwaningsih, Tripanjiasih Susmiarsih, Yenni Zulhamidah, Achmad Sofwan. The Concentration of Telomeric Repeat Binding Factor 2 (TERF2) in Leukocyte Cells of Patients with Hepatitis. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry 2024; 18(3): 249 doi: 10.1134/S1990750824600092
|
| 9 |
Shuangjing Zhu, Mengtao Yang, Ting Wang, Zhen Ding. Causal relationships between telomere length and liver disease: a Mendelian randomization study. Frontiers in Genetics 2023; 14 doi: 10.3389/fgene.2023.1164024
|
| 10 |
Liang-Jie Tang, Rafael S. Rios, Huai Zhang, Christopher D. Byrne, Giovanni Targher, Ming-Hua Zheng. Telomerase: a key player in the pathogenesis of non-alcoholic fatty liver disease?. Expert Review of Gastroenterology & Hepatology 2021; 15(7): 811 doi: 10.1080/17474124.2021.1903318
|
| 11 |
Mariana Nikolova-Karakashian. Sphingolipids in Cancer. Advances in Cancer Research 2018; 140: 155 doi: 10.1016/bs.acr.2018.05.002
|
| 12 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3007 doi: 10.1007/978-3-319-26956-6_167
|
| 13 |
Dorra Trad, Norsaf Bibani, Meriam Sabbah, Hela Elloumi, Dalila Gargouri, Asma Ouakaa, Jamel Kharrat. Known, new and emerging risk factors of hepatocellular carcinoma (review). La Presse Médicale 2017; 46(11): 1000 doi: 10.1016/j.lpm.2017.09.025
|
| 14 |
Peter H. Rej, Clarence C. Gravlee, Connie J. Mulligan. Shortened telomere length is associated with unfair treatment attributed to race in African Americans living in Tallahassee, Florida. American Journal of Human Biology 2020; 32(3) doi: 10.1002/ajhb.23375
|
| 15 |
Wan Huang, Weiping Zhou, Can Li, Yuan Yang, Yu-Kui Shang, Changsheng Chen, Jing Zhang, Rui Yao, Pei Wang, Wen Wen, Han-Qiang Liu, Ling Wang, Xia Li, Huijie Bian, Zhi-Nan Chen. Promoter mutations and cellular distribution of telomerase in non-clear cell and clear cell hepatocellular carcinoma. Oncotarget 2017; 8(16): 26288 doi: 10.18632/oncotarget.15458
|
| 16 |
Rodrigo del Brío Castillo, Jacob Bleesing, Thomas McCormick, James E. Squires, George V. Mazariegos, Judy Squires, Patrick J. McKiernan. Successful liver transplantation in short telomere syndromes without bone marrow failure due to DKC1 mutation. Pediatric Transplantation 2020; 24(3) doi: 10.1111/petr.13695
|
| 17 |
Donghee Kim, Andrew A. Li, Aijaz Ahmed. Leucocyte telomere shortening is associated with nonalcoholic fatty liver disease‐related advanced fibrosis. Liver International 2018; 38(10): 1839 doi: 10.1111/liv.13886
|
| 18 |
Filippo M. Panfili, Andrea Pietrobattista, Davide Vecchio, Michaela V. Gonfiantini, Andrea Bartuli, Marina Macchiaiolo. Commentary: Case report: Hereditary fibrosing poikiloderma with tendon contractures, myopathy, and pulmonary fibrosis (POIKTMP) presenting with liver cirrhosis and steroid-responsive interstitial pneumonia. Frontiers in Genetics 2023; 14 doi: 10.3389/fgene.2023.1255807
|
| 19 |
Kengo Yoshida, Munechika Misumi, Yoshiko Kubo, Mika Yamaoka, Seishi Kyoizumi, Waka Ohishi, Tomonori Hayashi, Yoichiro Kusunoki. Long-Term Effects of Radiation Exposure and Metabolic Status on Telomere Length of Peripheral Blood T Cells in Atomic Bomb Survivors. Radiation Research 2016; 186(4): 367 doi: 10.1667/RR14389.1
|
| 20 |
Zongwen Shuai, Miranda WY Leung, Xiaosong He, Weici Zhang, Guoxiang Yang, Patrick SC Leung, M Eric Gershwin. Adaptive immunity in the liver. Cellular & Molecular Immunology 2016; 13(3): 354 doi: 10.1038/cmi.2016.4
|
| 21 |
Hala M. Demerdash, Amany S. Elyamany, Emad Arida. Impact of direct-acting antivirals on leukocytic DNA telomere length in hepatitis C virus-related hepatic cirrhosis. European Journal of Gastroenterology & Hepatology 2019; 31(4): 494 doi: 10.1097/MEG.0000000000001306
|
| 22 |
Matthew Schade, Jacqueline A Sanabria, Milad Modarresi, Bryan Gillon, Zach Hunter, Jacqueline Fannin, Amrita Mallick, Henri Brunengraber, Juan Sanabria. Hepatocellular Carcinoma - Advances in Diagnosis and Treatment. 2018; doi: 10.5772/intechopen.71659
|
| 23 |
Abbey Barnard, Ashley Moch, Sammy Saab. Relationship between Telomere Maintenance and Liver Disease. Gut and Liver 2019; 13(1): 11 doi: 10.5009/gnl18081
|
| 24 |
Xiaodan Wang, Hao Deng, Jingyi Lin, Kai Zhang, Jingyu Ni, Lan Li, Guanwei Fan. Distinct roles of telomerase activity in age-related chronic diseases: An update literature review. Biomedicine & Pharmacotherapy 2023; 167: 115553 doi: 10.1016/j.biopha.2023.115553
|
| 25 |
Gaetano Bertino, Shirin Demma, Annalisa Ardiri, Maria Proiti, Giulia Malaguarnera, Nicoletta Bertino, Mariano Malaguarnera, Michele Malaguarnera. The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/731469
|
| 26 |
Francesca Pezzuto, Luigi Buonaguro, Franco M. Buonaguro, Maria Lina Tornesello. Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma. Infectious Agents and Cancer 2017; 12(1) doi: 10.1186/s13027-017-0138-5
|
| 27 |
Fayza A. Rahamtalla, Iman M. Shammat, Salma B. M. Mudawi, Maram Abbas, Mohammed A. H. Kheir Elsid , Mohammed S. M. Abdalla. Short Telomere Length in Plasma of Sudanese Patients with Hepatocellular Carcinoma and Chronic Liver Diseases. Sudan Journal of Medical Sciences 2024; 19(4): 460 doi: 10.18502/sjms.v19i4.16404
|
| 28 |
Michael Munroe, Evandro Luis Niero, Wilson Chun Fok, Alexandre Teixeira Vessoni, Ho‐Chang Jeong, Kirsten Ann Brenner, Luis Francisco Zirnberger Batista. Telomere Dysfunction Activates p53 and Represses HNF4α Expression Leading to Impaired Human Hepatocyte Development and Function. Hepatology 2020; 72(4): 1412 doi: 10.1002/hep.31414
|
| 29 |
Debora Goncalves da Silva, Nadyellem Graciano da Silva, Angelica Amorim Amato. Leukocyte telomere length in subjects with metabolic dysfunction-associated steatotic liver disease. Arab Journal of Gastroenterology 2024; 25(3): 293 doi: 10.1016/j.ajg.2024.06.005
|
| 30 |
Nermin M. Mohamed, Rania Hassan Mohamed, John F. Kennedy, Mahmoud M. Elhefnawi, Nadia M. Hamdy. A comprehensive review and in silico analysis of the role of survivin (BIRC5) in hepatocellular carcinoma hallmarks: A step toward precision. International Journal of Biological Macromolecules 2025; 311: 143616 doi: 10.1016/j.ijbiomac.2025.143616
|
| 31 |
Kai Zhou, Xingyu Liu, Mingda Wang, Jinjiang Duan, Xu Zhao, Hanjun Yin. The landscape in telomere related gene prognostic signature for survival and medication treatment effectiveness prediction in hepatocellular carcinoma. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01659-w
|
| 32 |
Hua-Hua Zhong, Shao-Jie Hu, Bo Yu, Sha-Sha Jiang, Jin Zhang, Dan Luo, Mei-Wen Yang, Wan-Ying Su, Ya-Lan Shao, Hao-Lin Deng, Fen-Fang Hong, Shu-Long Yang. Apoptosis in the aging liver. Oncotarget 2017; 8(60): 102640 doi: 10.18632/oncotarget.21123
|
| 33 |
Francesca Pezzuto, Francesco Izzo, Luigi Buonaguro, Clorinda Annunziata, Fabiana Tatangelo, Gerardo Botti, Franco M. Buonaguro, Maria Lina Tornesello. Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma. Oncotarget 2016; 7(34): 54253 doi: 10.18632/oncotarget.9801
|
| 34 |
A.A. Adelakun, I.O. Adediji, O.J. Idowu, T.F. Jegede, A.S. Oluremi, P.O. Adepoju, O.A. Olaniyan. Prognostic significance of serum telomerase activity in the monitoring of hepatitis B viral infection. Journal of Immunoassay and Immunochemistry 2022; 43(3): 299 doi: 10.1080/15321819.2021.2004162
|
| 35 |
Haiyan Cao, Yulong Zhai, Xiaoying Ji, Yaya Wang, Jing Zhao, Jinliang Xing, Jiaze An, Tingting Ren. Noncoding telomeric repeat‐containing RNA inhibits the progression of hepatocellular carcinoma by regulating telomerase‐mediated telomere length. Cancer Science 2020; 111(8): 2789 doi: 10.1111/cas.14442
|
| 36 |
Lucia Carulli. Telomere shortening as genetic risk factor of liver cirrhosis. World Journal of Gastroenterology 2015; 21(2): 379-383 doi: 10.3748/wjg.v21.i2.379
|
| 37 |
Wanvisa Udomsinprasert, Yong Poovorawan, Voranush Chongsrisawat, Paisarn Vejchapipat, Dong Zhan, Sittisak Honsawek, Gabriele Saretzki. Telomere Length in Peripheral Blood Leukocytes Is Associated with Severity of Biliary Atresia. PLOS ONE 2015; 10(7): e0134689 doi: 10.1371/journal.pone.0134689
|
| 38 |
Ayesha Khalid, Tabinda Hussain, Sobia Manzoor, Muhammad Saalim, Saba Khaliq. PTEN: A potential prognostic marker in virus-induced hepatocellular carcinoma. Tumor Biology 2017; 39(6): 101042831770575 doi: 10.1177/1010428317705754
|
| 39 |
Keerti Vishwakarma, Rajdeep Dey, Hardik Bhatt. Telomerase: A prominent oncological target for development of chemotherapeutic agents. European Journal of Medicinal Chemistry 2023; 249: 115121 doi: 10.1016/j.ejmech.2023.115121
|
| 40 |
Tingting Shi, Xingxin Yang, Hongping Zhou, Jianjun Xi, Jingjing Sun, Yunling Ke, Jiankang Zhang, Yidan Shao, Xiaojie Jiang, Xuwang Pan, Shourong Liu, Rangxiao Zhuang, Jordi Gracia-Sancho. Activated carbon N-acetylcysteine microcapsule protects against nonalcoholic fatty liver disease in young rats via activating telomerase and inhibiting apoptosis. PLOS ONE 2018; 13(1): e0189856 doi: 10.1371/journal.pone.0189856
|
| 41 |
Peter H. Rej, Robert L. Tennyson, Nanette R. Lee, Dan T.A. Eisenberg. Years of caregiving for chronically ill and disabled family members is not associated with telomere length in the Philippines. Psychoneuroendocrinology 2019; 103: 188 doi: 10.1016/j.psyneuen.2019.01.019
|
| 42 |
Lior Charach, Lior Zusmanovitch, Gideon Charach. Hepatocellular Carcinoma. Part 1: Epidemiology, Risk Factors, Pathogenesis, and Pathology. EMJ Hepatology 2017; : 75 doi: 10.33590/emjhepatol/10312421
|